Wellmont Cancer Institute
1 Medical Park Boulevard
Bristol, Tennessee 37620
Bristol, Tennessee 37620
We've found
1 trials
at this facility
Her2 Positive Breast Cancer Clinical Trial
Updated: 12/31/1969
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials